The effects of dexamethasone on cigarette smoke induced gene expression changes in COPD macrophages

International Immunopharmacology

Volumn 10, Issue 1, 2010, Pages 57-64

  Kent, Lauren M ^a   Fox, Steve M ^b   Farrow, Stuart N ^b   Singh, Dave ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

COPD; Cytokine; Dexamethasone; Macrophage; Microarray

Indexed keywords

CHEMOKINE; CIGARETTE SMOKE CONDENSATE; CYTOKINE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MALE; PRIORITY JOURNAL; UPREGULATION;

AGED; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MACROPHAGES; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 73249148029     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.09.021     Document Type: Article

References (51)

1. Barnes P.J. New concepts in chronic obstructive pulmonary disease. Ann Rev Med 54 1 (2003) 113-129
2. Barnes P.J. Corticosteroids: the drugs to beat. Eur J Pharmacol 533 1-3 (2006) 2
3. Soriano J.B., Sin D.D., Zhang X., Camp P.G., Anderson J.A., Anthonisen N.R., et al. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest 131 3 (March 1, 2007) 682-689 2007
4. Culpitt S.V., Rogers D.F., Shah P., De Matos C., Russell R.E.K., Donnelly L.E., et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167 1 (January 1, 2003) 24-31 2003
5. Cosio B.G., Tsaprouni L., Ito K., Jazrawi E., Adcock I.M., and Barnes P.J. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 200 5 (September 7, 2004) 689-695 2004
6. Moodie F.M., Marwick J.A., Anderson C.S., Szulakowski P., Biswas S.K., Bauter M.R., et al. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-κB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J (September 28, 2004) 04-1506fje 2004
7. Kent L.M., Smyth L.J.C., Plumb J., Clayton C.L., Fox S.M., Ray D.W., et al. Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N′-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl) -7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504). J Pharmacol Exp Ther 328 2 (February 1, 2009) 458-468 2009
8. Stengel D., Antonucci M., Gaoua W., Dachet C., Lesnik P., Hourton D., et al. Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine. Arterioscler Thromb Vasc Biol 18 7 (July 1, 1998) 1172-1180 1998
9. Tudhope S.J., Finney-Hayward T.K., Nicholson A.G., Mayer R.J., Barnette M.S., Barnes P.J., et al. Different mitogen-activated protein kinase-dependent cytokine responses in cells of the monocyte lineage. J Pharmacol Exp Ther 324 1 (January 1, 2008) 306-312 2008
10. Glass C.K., and Ogawa S. Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 6 1 (2006) 44
11. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122 5 (2005) 707
12. Kent L., Smyth L., Clayton C., Scott L., Cook T., Stephens R., et al. Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine 42 2 (2008) 205
13. Birrell M., Wong S., Catley M., and Belvisi M.G. Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol 214 1 (2008) 27-37
14. Anzueto A., Sethi S., and Martinez F.J. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4 7 (October 1, 2007) 554-564 2007
15. Calverley P.M.A., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 8 (February 22, 2007) 775-789 2007
16. Singh D. Salmeterol/fluticasone propionate combination in the treatment of COPD. Expert Rev Respir Med 1 1 (2007) 25-33
17. GOLD. Global strategy for diagnosis, management, and prevention of COPD. www.goldcopd.com. 2006.
18. Weng L., Dai H., Zhan Y., He Y., Stepaniants S.B., and Bassett D.E. Rosetta error model for gene expression analysis. Bioinformatics 22 9 (May 1, 2006) 1111-1121 2006
19. Juric D., Lacayo N.J., Ramsey M.C., Racevskis J., Wiernik P.H., Rowe J.M., et al. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. J Clin Oncol 25 11 (April 10, 2007) 1341-1349 2007
20. Li X., Liu H., Qin L., Tamasi J., Bergenstock M., Shapses S., et al. Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J Biol Chem 282 45 (November 9, 2007) 33086-33097 2007
21. Savli H., Szendr A., Romics I., and Nagy B. Gene network and canonical pathway analysis in prostate cancer: a microarray study. Exp Mol Med 40 2 (April 2008) 176-185 2008
22. Chen H., Cowan M.J., Hasday J.D., Vogel S.N., and Medvedev A.E. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-{kappa}B in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol 179 9 (November 1, 2007) 6097-6106 2007
23. Facchinetti F., Amadei F., Geppetti P., Tarantini F., Di Serio C., Dragotto A., et al. {alpha},beta-Unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am J Respir Cell Mol Biol 37 5 (November 1, 2007) 617-623 2007
24. Karimi K., Sarir H., Mortaz E., Smit J., Hosseini H., De Kimpe S., et al. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res 7 1 (2006) 66
25. Walters M.J., Paul-Clark M.J., McMaster S.K., Ito K., Adcock I.M., and Mitchell J.A. Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: implications for steroid resistance. Mol Pharmacol 68 5 (November 1, 2005) 1343-1353 2005
26. Blank V., and Andrews N.C. The Maf transcription factors: regulators of differentiation. Trends Biochem Sci 22 11 (1997) 437-441
27. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 4 5 (2002) E131-E136
28. Motohashi H., Katsuoka F., Shavit J.A., Engel J.D., and Yamamoto M. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell 103 6 (2000) 865-876
29. Suzuki T., Okuno H., Yoshida T., Endo T., Nishina H., and Iba H. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucl Acids Res 19 20 (October 25, 1991) 5537-5542 1991
30. Wisdon R., and Verma I.M. Transformation by Fos proteins requires a C-terminal transactivation domain. Mol Cell Biol 13 12 (December 1, 1993) 7429-7438 1993
31. Blank V. Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?. J Mol Biol 376 (2008) 913-925
32. Barnes P.J., Ito K., and Adcock I.M. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 363 9410 (2004) 731-733
33. Drost E.M., Skwarski K.M., Sauleda J., Soler N., Roca J., Agusti A., et al. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 60 4 (April 1, 2005) 293-300 2005
34. Keatings V.M., Collins P.D., Scott D.M., and Barnes P.J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153 2 (February 1, 1996) 530-534 1996
35. Kane B., Kolsum U., Southworth T., Armstrong J., Woodcock A., and Singh D. The effects of smoking on the lipopolysaccharide response and glucocorticoid sensitivity of alveolar macrophages from asthmatics. Chest 136 1 (2009) 163-170
36. Meng Q., Gideon K., Harbo S., Renne R., Lee M., Brys A., et al. Gene expression profiling in lung tissues from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation. Inhal Toxicol 18 8 (2006) 555
37. Shapiro S.D. Proteolysis in the lung. Eur Respir J 22 44_suppl (September 20, 2003) 30s-2 2003
38. Sudhakaran P.R., Radhika A., and Jacob S.S. Monocyte macrophage differentiation in vitro: fibronectin-dependent upregulation of certain macrophage-specific activities. Glycoconj J 24 1 (2007) 49-55
39. Aoshiba K., Tamaoki J., and Nagai A. Acute cigarette smoke exposure induces apoptosis of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 281 6 (December 1, 2001) L1392-L1401 2001
40. Chen H.-W., Chien M.-L., Chaung Y.-H., Lii C.-K., and Wang T.-S. Extracts from cigarette smoke induce DNA damage and cell adhesion molecule expression through different pathways. Chem Biol Interact 150 3 (2004) 233
41. Culpitt S.V., Rogers D.F., Fenwick P.S., Shah P., De Matos C., Russell R.E.K., et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58 11 (November 1, 2003) 942-946 2003
42. Hoshino S., Yoshida M., Inoue K., Yano Y., Yanagita M., Mawatari H., et al. Cigarette smoke extract induces endothelial cell injury via JNK pathway. Biochem Biophys Res Commun 329 1 (2005) 58
43. Kode A., Yang S.-R., and Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res 7 1 (2006) 132
44. Laan M., Bozinovski S., and Anderson G.P. Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J Immunol 173 6 (September 15, 2004) 4164-4170 2004
45. Russell R.E.K., Culpitt S.V., DeMatos C., Donnelly L., Smith M., Wiggins J., et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 26 5 (May 1, 2002) 602-609 2002
46. Wang H.-Y., Ye Y.-N., Zhu M., and Cho C.-H. Increased interleukin-8 expression by cigarette smoke extract in endothelial cells. Environ Toxicol Pharmacol 9 1-2 (2000) 19
47. Wickenden J.A., Clarke M.C.H., Rossi A.G., Rahman I., Faux S.P., Donaldson K., et al. Cigarette smoke prevents apoptosis through inhibition of caspase activation and induces necrosis. Am J Respir Cell Mol Biol 29 5 (November 1, 2003) 562-570 2002-0235OC. 2003
48. Chapman R. Canine models of asthma and COPD. Pulm Pharmacol Ther 21 (2008) 731-742
49. Coggins C.R.E. A review of chronic inhalation studies with mainstream cigarette smoke in rats and mice. Toxicol Pathol 26 3 (May 1, 1998) 307-314 1998
50. Coggins C.R.E. Review article: a review of chronic inhalation studies with mainstream cigarette smoke, in hamsters, dogs, and nonhuman primates. Toxicol Pathol 29 5 (August 1, 2001) 550-557 2001
51. Zhang X., Liu G., Lenburg M., and Spira A. Comparison of smoking-induced gene expression on Affymetrix exon and 3′-based expression arrays. Genome Inform 18 (2007) 247-257